{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:21:29Z","timestamp":1791591689269,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T00:00:00Z","timestamp":1432771200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12894-015-0039-0","type":"journal-article","created":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T11:13:44Z","timestamp":1432811624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy"],"prefix":"10.1186","volume":"15","author":[{"given":"Michael A.","family":"Moriarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Uhlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan T.","family":"Bing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad R.","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep","family":"Deorah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth G.","family":"Nepple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,28]]},"reference":[{"key":"39_CR1","unstructured":"Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, http:\/\/seer.cancer.gov\/csr\/1975_2010\/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Accessed May 10, 2013."},{"key":"39_CR2","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1464-410X.2010.09675.x","volume":"107","author":"JD Raman","year":"2011","unstructured":"Raman JD, Messer J, Sielatycki JA, Hollenbeak CS. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973\u20132005. BJU Int. 2011;107:1059\u201364.","journal-title":"BJU Int"},{"key":"39_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"39_CR4","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.eururo.2013.03.032","volume":"63","author":"M Roupret","year":"2013","unstructured":"Roupret M, Babjuk M, Comperat E, et al. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol. 2013;63:1059\u201371.","journal-title":"Eur Urol"},{"key":"39_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.urology.2007.08.054","volume":"71","author":"T Terakawa","year":"2008","unstructured":"Terakawa T, Miyake H, Muramaki M, Takenaka A, Hara I, Fujisawa M. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. Urology. 2008;71:123\u20137.","journal-title":"Urology"},{"key":"39_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1046\/j.1464-410X.1997.00463.x","volume":"80","author":"M Racioppi","year":"1997","unstructured":"Racioppi M, D'Addessi A, Alcini A, Destito A, Alcini E. Clinical review of 100 consecutive surgically treated patients with upper urinary tract transitional tumours. Br J Urol. 1997;80:707\u201311.","journal-title":"Br J Urol"},{"key":"39_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.urology.2004.09.021","volume":"65","author":"Y Matsui","year":"2005","unstructured":"Matsui Y, Utsunomiya N, Ichioka K, et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology. 2005;65:279\u201383.","journal-title":"Urology"},{"key":"39_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/j.1464-410X.2005.05804.x","volume":"96","author":"JD Raman","year":"2005","unstructured":"Raman JD, Ng CK, Boorjian SA, Vaughan Jr ED, Sosa RE, Scherr DS. Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology. BJU Int. 2005;96:1031\u20135.","journal-title":"BJU Int"},{"key":"39_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.eururo.2012.01.021","volume":"61","author":"EK Cha","year":"2012","unstructured":"Cha EK, Shariat SF, Kormaksson M, et al. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol. 2012;61:818\u201325.","journal-title":"Eur Urol"},{"key":"39_CR10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","volume":"60","author":"T O'Brien","year":"2011","unstructured":"O'Brien T, Ray E, Singh R, Coker B, Beard R. British association of urological surgeons section of O. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative Intravesical dose of mitomycin C (the ODMIT-C trial). Eur Urol. 2011;60:703\u201310.","journal-title":"Eur Urol"},{"key":"39_CR11","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1200\/JCO.2012.45.2128","volume":"31","author":"A Ito","year":"2013","unstructured":"Ito A, Shintaku I, Satoh M, et al. Prospective randomized phase II trial of a single early Intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy study group trial. J Clin Oncol. 2013;31:1422\u20137.","journal-title":"J Clin Oncol"},{"key":"39_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0140-6736(92)90135-P","volume":"339","author":"J Lunec","year":"1992","unstructured":"Lunec J, Challen C, Wright C, Mellon K, Neal DE. c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder. Lancet. 1992;339:439\u201340.","journal-title":"Lancet"},{"key":"39_CR13","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/0140-6736(93)92066-3","volume":"342","author":"T Habuchi","year":"1993","unstructured":"Habuchi T, Takahashi R, Yamada H, Kakehi Y, Sugiyama T, Yoshida O. Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet. 1993;342:1087\u20138.","journal-title":"Lancet"},{"key":"39_CR14","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1056\/NEJM199203123261104","volume":"326","author":"D Sidransky","year":"1992","unstructured":"Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B. Clonal origin bladder cancer. N Engl J Med. 1992;326:737\u201340.","journal-title":"N Engl J Med"},{"key":"39_CR15","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0046-8177(99)90037-0","volume":"30","author":"M Li","year":"1999","unstructured":"Li M, Cannizzaro LA. Identical clonal origin of synchronous and metachronous low- grade, noninvasive papillary transitional cell carcinomas of the urinary tract. Hum Pathol. 1999;30:1197\u2013200.","journal-title":"Hum Pathol"},{"key":"39_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.bjc.6690643","volume":"81","author":"I Fadl-Elmula","year":"1999","unstructured":"Fadl-Elmula I, Gorunova L, Mandahl N, et al. Cytogenetic monoclonality in multifocal uroepithelial carcinomas: evidence of intraluminal tumour seeding. Br J Cancer. 1999;81:6\u201312.","journal-title":"Br J Cancer"},{"key":"39_CR17","doi-asserted-by":"crossref","unstructured":"Perlis N ZA, Beyene J, Finelli A, Fleshner NE, and Kulkarni GS. Immediate Post\u2013 Transurethral Resection of Bladder Tumor Intravesical Chemotherapy Prevents Non\u2013 Muscle-invasive Bladder Cancer Recurrences: An Updated Meta-analysis on 2548 Patients and Quality-of-Evidence Review. Eur Urol. 2013;64(3):421\u201330.","DOI":"10.1016\/j.eururo.2013.06.009"},{"key":"39_CR18","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1097\/01.ju.0000125486.92260.b2","volume":"171","author":"RJ Sylvester","year":"2004","unstructured":"Sylvester RJ, Oosterlinck W, van der Meijden AP. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol. 2004;171:2186\u201390. quiz 435.","journal-title":"J Urol"},{"key":"39_CR19","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/S0022-5347(01)66226-8","volume":"155","author":"DA Tolley","year":"1996","unstructured":"Tolley DA, Parmar MK, Grigor KM, et al. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7\u00a0years of follow up. J Urol. 1996;155:1233\u20138.","journal-title":"J Urol"},{"key":"39_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1464-410X.2006.05965.x","volume":"97","author":"AH Mostafid","year":"2006","unstructured":"Mostafid AH, Rajkumar RG, Stewart AB, Singh R. Immediate administration of intravesical mitomycin C after tumour resection for superficial bladder cancer. BJU Int. 2006;97:509\u201312.","journal-title":"BJU Int"},{"key":"39_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg"},{"key":"39_CR22","first-page":"518","volume":"111","author":"PA Clavien","year":"1992","unstructured":"Clavien PA, Sanabria JR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery. 1992;111:518\u201326.","journal-title":"Surgery"},{"key":"39_CR23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-5347(17)34864-4","volume":"151","author":"H Sekine","year":"1994","unstructured":"Sekine H, Fukui I, Yamada T, Ohwada F, Yokokawa M, Ohshima H. Intravesical mitomycin C and doxorubicin sequential therapy for carcinoma in situ of the bladder: a longer followup result. J Urol. 1994;151:27\u201330.","journal-title":"J Urol"},{"key":"39_CR24","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S0022-5347(01)61606-9","volume":"161","author":"E Solsona","year":"1999","unstructured":"Solsona E, Iborra I, Ricos JV, Monros JL, Casanova J, Dumont R. Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer:short and long-term followup. J Urol. 1999;161:1120\u20133.","journal-title":"J Urol"},{"key":"39_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0094-0143(05)70240-8","volume":"27","author":"JL Duque","year":"2000","unstructured":"Duque JL, Loughlin KR. An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy. Urol Clin North Am. 2000;27:125\u201335.","journal-title":"Urol Clin North Am"},{"issue":"9","key":"39_CR26","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S1470-2045(11)70190-5","volume":"12","author":"SM Di Stasi","year":"2011","unstructured":"Di Stasi SM, Valenti M, Verri C, et al. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non- muscle invasive bladder cancer: a randomised controlled trial. Lancet Oncol. 2011;12(9):871\u20139.","journal-title":"Lancet Oncol"},{"issue":"6","key":"39_CR27","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1016\/j.juro.2013.06.025","volume":"190","author":"DA Barocas","year":"2013","unstructured":"Barocas DA, Liu A, Burks FN, et al. Practice-based collaboration to improve the use of immediate intravesical therapy after resection for non-muscle-invasive bladder cancer. J Urol. 2013;190(6):2011\u20136.","journal-title":"J Urol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12894-015-0039-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-015-0039-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-015-0039-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-015-0039-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T14:10:58Z","timestamp":1630591858000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-015-0039-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,28]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["39"],"URL":"https:\/\/doi.org\/10.1186\/s12894-015-0039-0","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,28]]},"assertion":[{"value":"8 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"45"}}